Search

Search Constraints

You searched for: Author/Creator Moskowitz, Alan J.

Search Results

1. Costs of telaprevir‐based triple therapy for hepatitis C: $189, 000 per sustained virological response. Issue 4 (25th August 2014)

2. Cost‐effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: A cost‐utility analysis. Issue 4 (30th June 2015)

3. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. Issue 5 (May 2022)

4. Functional impairments for outcomes in a randomized trial of unruptured brain AVMs. (3rd October 2017)

5. Preferences and utilities for health states after treatment for oropharyngeal cancer: Transoral robotic surgery versus definitive (chemo)radiotherapy. Issue 7 (19th May 2014)